Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coinbase Global, Inc. (COIN) vs Medpace Holdings Inc (MEDP) Price & Performance

Coinbase Global, Inc.Trade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Coinbase Global, Inc. vs Medpace Holdings Inc — how do they compare? Coinbase Global, Inc. trades at $149.34 (market cap $39.20B), while Medpace Holdings Inc trades at $597.39 (market cap $16.90B). The key difference: Coinbase Global, Inc. is far larger — about 2.3× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.

COINMEDP
Market Cap
$39.20B$16.90B
Sector
TechnologyTechnology
52-Week High
$387.27$620.59
52-Week Low
$141.09$393.42
Enterprise Value
$36.85B$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coinbase Global, Inc.

COIN trades at $150.35, up 1.12% with bearish technical signals but strong analyst support (55% buy ratings). The company reported mixed Q2 2026 results with revenue and EPS misses, though it achieved a record 10.3% global trading volume share. Fundamentals show revenue growth from $3.1B in 2023 to $7.2B in 2025, but profitability remains volatile with recent quarterly losses.

The stock faces near-term pressure from earnings misses and crypto market volatility, but long-term potential exists through business diversification beyond retail trading. Key risks include competitive threats and regulatory uncertainty, while the $207.20 consensus price target suggests 38% upside if execution improves.

Medpace Holdings Inc

MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.

MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Coinbase Global, Inc.

Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.

Read more on COIN

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP